Get the Stockscreener App
0.0001
0.00%
0.00
U.S. Stem Cell Inc Stock (USRM) Forecast
The U.S. Stem Cell Inc (USRM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.00826, representing a +8,163% increase from the current price of $0.0001. The highest analyst price target is $0.00769, and the lowest is $0.00883.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month USRM Price Target
Average 0.0099
(+9,797% Upside)
Long-term USRM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about U.S. Stem Cell Inc financial reports and earnings history, U.S. Stem Cell Inc (USRM) stock could reach $0.0285 by 2030, $0.0903 by 2040 and $0.1014 by 2050. See the projected annual prices until 2050 of the U.S. Stem Cell Inc stock below:
- U.S. Stem Cell Inc (USRM) is expected to reach an average price of $0.0539 in 2035, with a high prediction of $0.0588 and a low estimate of $0.0548. This indicates an $53,819% rise from the last recorded price of $0.0001.
- U.S. Stem Cell Inc (USRM) stock is projected to chart a bullish course in 2040, with an average price target of $0.0846, representing an $84,512% surge from its current level. The forecast ranges from a conservative $0.0855 to a sky-high $0.0903.
- Our analysts predict U.S. Stem Cell Inc (USRM) to jump 117.09K% by 2045, soaring from $0.0749 to an average price of $0.1172, potentially reaching $0.1206. While $0.0749 is the low estimate, the potential upside is significant.
- U.S. Stem Cell Inc (USRM) stock is expected to climb by 2050, reaching an average of $0.0971, a $97,038% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.1014 and $0.0929, respectively, highlighting the market's uncertainty.
U.S. Stem Cell Inc Stock (USRM) Year by Year Forecast
U.S. Stem Cell Inc Stock (USRM) Price Forecast for 2025
U.S. Stem Cell Inc Stock (USRM) is expected to reach an average price of $0.00776 in 2025, with a high prediction of $0.0114 and a low estimate of $0.00412. This indicates an +7,659% rise from the last recorded price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.00683 | $0.00883 | $0.00769 | +6,734% |
| June, 2025 | $0.00757 | $0.00728 | $0.00603 | +7,473% |
| July, 2025 | $0.00696 | $0.00692 | $0.00582 | +6,864% |
| August, 2025 | $0.00636 | $0.00686 | $0.00596 | +6,255% |
| September, 2025 | $0.011 | $0.00579 | $0.0114 | +10,906% |
| October, 2025 | $0.0105 | $0.0114 | $0.0107 | +10,429% |
| November, 2025 | $0.00755 | $0.00955 | $0.0081 | +7,451% |
| December, 2025 | $0.00918 | $0.00928 | $0.00816 | +9,080% |
U.S. Stem Cell Inc Stock (USRM) Price Forecast for 2026
The predicted value for U.S. Stem Cell Inc (USRM) in 2026 is set at an average of $0.012. Estimates vary from a peak of $0.0166 to a trough of $0.00747, indicating an +11,934% surge from the present price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0086 | $0.00889 | $0.00779 | +8,503% |
| February, 2026 | $0.00633 | $0.00747 | $0.00776 | +6,226% |
| March, 2026 | $0.0132 | $0.00793 | $0.014 | +13,091% |
| April, 2026 | $0.0114 | $0.0134 | $0.0126 | +11,346% |
| May, 2026 | $0.0113 | $0.0118 | $0.0104 | +11,150% |
| June, 2026 | $0.0108 | $0.0109 | $0.0102 | +10,719% |
| July, 2026 | $0.00987 | $0.0104 | $0.00956 | +9,774% |
| August, 2026 | $0.0161 | $0.00914 | $0.0166 | +16,022% |
| September, 2026 | $0.0153 | $0.0162 | $0.0157 | +15,208% |
| October, 2026 | $0.012 | $0.0141 | $0.0126 | +11,895% |
| November, 2026 | $0.0132 | $0.0133 | $0.0124 | +13,103% |
| December, 2026 | $0.0123 | $0.0128 | $0.0117 | +12,190% |
U.S. Stem Cell Inc Stock (USRM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for U.S. Stem Cell Inc (USRM) is $0.0163, with a high forecast of $0.0218 and a low forecast of $0.0108. This indicates an +16,210% increase from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.00968 | $0.0108 | $0.0114 | +9,576% |
| February, 2027 | $0.0191 | $0.0112 | $0.0192 | +18,969% |
| March, 2027 | $0.0161 | $0.0181 | $0.0179 | +15,957% |
| April, 2027 | $0.0155 | $0.0163 | $0.0149 | +15,426% |
| May, 2027 | $0.0147 | $0.0148 | $0.0144 | +14,574% |
| June, 2027 | $0.0134 | $0.0139 | $0.0132 | +13,292% |
| July, 2027 | $0.0219 | $0.0125 | $0.0218 | +21,800% |
| August, 2027 | $0.0201 | $0.021 | $0.0212 | +19,988% |
| September, 2027 | $0.0164 | $0.0186 | $0.0172 | +16,338% |
| October, 2027 | $0.0168 | $0.0178 | $0.0167 | +16,688% |
| November, 2027 | $0.016 | $0.0168 | $0.0159 | +15,876% |
| December, 2027 | $0.013 | $0.0142 | $0.015 | +12,926% |
U.S. Stem Cell Inc Stock (USRM) Price Forecast for 2028
In 2028, U.S. Stem Cell Inc (USRM) is projected to reach an average price of $0.022, with a high projection of $0.0296 and a low estimate of $0.0145. This indicates an +21,932% rise from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0231 | $0.0145 | $0.0244 | +22,987% |
| February, 2028 | $0.0207 | $0.0227 | $0.0223 | +20,569% |
| March, 2028 | $0.0198 | $0.0207 | $0.0194 | +19,701% |
| April, 2028 | $0.0176 | $0.0187 | $0.0185 | +17,533% |
| May, 2028 | $0.0169 | $0.0174 | $0.017 | +16,810% |
| June, 2028 | $0.0271 | $0.0158 | $0.027 | +27,000% |
| July, 2028 | $0.0249 | $0.0258 | $0.0264 | +24,767% |
| August, 2028 | $0.0209 | $0.0231 | $0.0219 | +20,781% |
| September, 2028 | $0.0209 | $0.0219 | $0.021 | +20,795% |
| October, 2028 | $0.0197 | $0.0207 | $0.0199 | +19,563% |
| November, 2028 | $0.0164 | $0.0175 | $0.0186 | +16,277% |
| December, 2028 | $0.0291 | $0.0177 | $0.0296 | +29,033% |
U.S. Stem Cell Inc Stock (USRM) Price Forecast for 2029
The 2029 price forecast for U.S. Stem Cell Inc Stock (USRM) is $0.027 on average, with a high prediction of $0.0348 and a low estimate of $0.0192. This represents an +26,897% increase from the previous price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0253 | $0.0273 | $0.0278 | +25,180% |
| February, 2029 | $0.0241 | $0.0249 | $0.0239 | +23,976% |
| March, 2029 | $0.0216 | $0.0227 | $0.0227 | +21,472% |
| April, 2029 | $0.0204 | $0.0209 | $0.0209 | +20,329% |
| May, 2029 | $0.0323 | $0.0192 | $0.0322 | +32,200% |
| June, 2029 | $0.0312 | $0.0312 | $0.0315 | +31,078% |
| July, 2029 | $0.0253 | $0.0277 | $0.0291 | +25,225% |
| August, 2029 | $0.025 | $0.026 | $0.0253 | +24,902% |
| September, 2029 | $0.023 | $0.0245 | $0.0239 | +22,880% |
| October, 2029 | $0.0197 | $0.0209 | $0.0222 | +19,627% |
| November, 2029 | $0.0342 | $0.021 | $0.0348 | +34,065% |
| December, 2029 | $0.0299 | $0.0319 | $0.0328 | +29,792% |
U.S. Stem Cell Inc Stock (USRM) Price Forecast for 2030
U.S. Stem Cell Inc Stock (USRM) is expected to reach an average price of $0.0313 in 2030, with a high forecast of $0.04 and a low forecast of $0.0225. This signifies an +31,172% surge from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0284 | $0.0292 | $0.0285 | +28,251% |
| February, 2030 | $0.0255 | $0.0266 | $0.0269 | +25,410% |
| March, 2030 | $0.0243 | $0.0249 | $0.0247 | +24,220% |
| April, 2030 | $0.0375 | $0.0225 | $0.0374 | +37,400% |
| May, 2030 | $0.036 | $0.0361 | $0.0366 | +35,941% |
| June, 2030 | $0.0313 | $0.0322 | $0.0339 | +31,183% |
| July, 2030 | $0.0291 | $0.0301 | $0.0298 | +29,009% |
| August, 2030 | $0.0268 | $0.0284 | $0.0279 | +26,650% |
| September, 2030 | $0.0231 | $0.0242 | $0.0258 | +22,977% |
| October, 2030 | $0.0392 | $0.0243 | $0.04 | +39,097% |
| November, 2030 | $0.0341 | $0.0377 | $0.0377 | +33,960% |
| December, 2030 | $0.0326 | $0.0335 | $0.033 | +32,526% |
0.67%
0.02%
Cap:
|
Volume (24h):